Company Profiles

driven by the PitchBook Platform

Novimmune

Description

Provider of drug discovery and development services for the treatment of inflammatory diseases. The company develops therapeutic monoclonal antibodies for the treatment of inflammatory diseases, immune-related disorders and cancer.

1998

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$29.8M

Latest Deal Amount

$247M

Total Amount Raised

Description

Provider of drug discovery and development services for the treatment of inflammatory diseases. The company develops therapeutic monoclonal antibodies for the treatment of inflammatory diseases, immune-related disorders and cancer.

Website:

www.novimmune.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

14 Chemin des Aulx Plan-Les-Ouates 1228 GenevaSwitzerland +41 (0)22 839 7141
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Novimmune's full profile, request a free trial.

Novimmune Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Novimmune Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Affentranger AssociatesVenture CapitalMinority000 0000000 0000
AravisVenture CapitalMinority000 0000000 0000
Aventic PartnersPE/BuyoutMinority000 0000000 0000
BZ BankOtherMinority000 0000000 0000
Endeavour VisionVenture CapitalMinority000 0000000 0000
Affentranger Associates Venture Capital
Aravis Venture Capital
Aventic Partners PE/Buyout
BZ Bank Other
Endeavour Vision Venture Capital

Novimmune Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Andrew OakleyChief Financial Officer
Marie Kosco-Vilbois Ph.DChief Scientific Officer
Nathalie MullerDirector of Legal Affairs, Administration and Intellectual Property
Adrian MillsChief Business Officer
Cristina De Min MDChief Medical Officer
Andrew Oakley Chief Financial Officer
Marie Kosco-Vilbois Ph.D Chief Scientific Officer
Nathalie Muller Director of Legal Affairs, Administration and Intellectual Property
Adrian Mills Chief Business Officer
Cristina De Min MD Chief Medical Officer

Novimmune Board Members (7)

NameRepresentingRoleSinceContact
Info
Eduard Holdener MDSelfChairman of the Board of Director & Chief Executive Officer000 0000
Feisal Abukscem Ph.DSelfBoard Member000 0000
Florent GrosNovartis Venture FundsManaging Director000 0000
Jack BarbutNovimmuneBoard Member000 0000
Jonathan Hepple Ph.DRosetta Capital(London)Co-Founder & Partner000 0000
Eduard Holdener MD Chairman of the Board of Director & Chief Executive Officer Self
Feisal Abukscem Ph.D Board Member Self
Florent Gros Managing Director Novartis Venture Funds
Jack Barbut Board Member Novimmune
Jonathan Hepple Ph.D Co-Founder & Partner Rosetta Capital(London)
Request full access to PitchBook